Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Infinity Pharmaceuticals patents

Patents where

Current Assignee

Name

Infinity Pharmaceuticals

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 8940742 Heterocyclic compounds and uses thereof	Patent 8940742 was granted and assigned to Infinity Pharmaceuticals on January, 2015 by the United States Patent and Trademark Office.		Infinity Pharmaceuticals	United States Patent and Trademark Office	8940742	January 27, 2015
‌ US Patent 7947670 Ansamycin formulations and methods of use thereof	Patent 7947670 was granted and assigned to Infinity Pharmaceuticals on May, 2011 by the United States Patent and Trademark Office.		Infinity Pharmaceuticals	United States Patent and Trademark Office	7947670	May 24, 2011
‌ US Patent 8969363 Heterocyclic compounds and uses thereof	Patent 8969363 was granted and assigned to Infinity Pharmaceuticals on March, 2015 by the United States Patent and Trademark Office.		Infinity Pharmaceuticals	United States Patent and Trademark Office	8969363	March 3, 2015
‌ US Patent 9056877 Heterocyclic compounds and uses thereof	Patent 9056877 was granted and assigned to Infinity Pharmaceuticals on June, 2015 by the United States Patent and Trademark Office.		Infinity Pharmaceuticals	United States Patent and Trademark Office	9056877	June 16, 2015
‌ US Patent 7566706 Analogs of benzoquinone-containing ansamycins and methods of use thereof	Patent 7566706 was granted and assigned to Infinity Pharmaceuticals on July, 2009 by the United States Patent and Trademark Office.		Infinity Pharmaceuticals	United States Patent and Trademark Office	7566706	July 28, 2009
‌ US Patent 7608613 Analogs of benzoquinone-containing ansamycins and methods of use thereof	Patent 7608613 was granted and assigned to Infinity Pharmaceuticals on October, 2009 by the United States Patent and Trademark Office.		Infinity Pharmaceuticals	United States Patent and Trademark Office	7608613	October 27, 2009
‌ US Patent 7579337 Analogs of benzoquinone-containing ansamycins and methods of use thereof	Patent 7579337 was granted and assigned to Infinity Pharmaceuticals on August, 2009 by the United States Patent and Trademark Office.		Infinity Pharmaceuticals	United States Patent and Trademark Office	7579337	August 25, 2009
‌ US Patent 7375217 Analogs of benzoquinone-containing ansamycins and methods of use thereof	Patent 7375217 was granted and assigned to Infinity Pharmaceuticals on May, 2008 by the United States Patent and Trademark Office.		Infinity Pharmaceuticals	United States Patent and Trademark Office	7375217	May 20, 2008
‌ US Patent 7282493 Analogs of benzoquinone-containing ansamycins and methods of use thereof	Patent 7282493 was granted and assigned to Infinity Pharmaceuticals on October, 2007 by the United States Patent and Trademark Office.		Infinity Pharmaceuticals	United States Patent and Trademark Office	7282493	October 16, 2007
‌ US Patent 7361647 Analogs of benzoquinone-containing ansamycins and methods of use thereof	Patent 7361647 was granted and assigned to Infinity Pharmaceuticals on April, 2008 by the United States Patent and Trademark Office.		Infinity Pharmaceuticals	United States Patent and Trademark Office	7361647	April 22, 2008
‌ US Patent 9388183 Heterocyclic compounds and uses thereof	Patent 9388183 was granted and assigned to Infinity Pharmaceuticals on July, 2016 by the United States Patent and Trademark Office.	Infinity Pharmaceuticals	Infinity Pharmaceuticals	United States Patent and Trademark Office	9388183	July 12, 2016
‌ US Patent 9359365 Heterocyclic compounds and uses thereof	Patent 9359365 was granted and assigned to Infinity Pharmaceuticals on June, 2016 by the United States Patent and Trademark Office.	Infinity Pharmaceuticals	Infinity Pharmaceuticals	United States Patent and Trademark Office	9359365	June 7, 2016
‌ US Patent 11312718 Formulations of (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one	Patent 11312718 was granted and assigned to Infinity Pharmaceuticals on April, 2022 by the United States Patent and Trademark Office.	Infinity Pharmaceuticals	Infinity Pharmaceuticals	United States Patent and Trademark Office	11312718	April 26, 2022
‌ US Patent 11110096 Combination therapies	Patent 11110096 was granted and assigned to Infinity Pharmaceuticals on September, 2021 by the United States Patent and Trademark Office.	Infinity Pharmaceuticals	Infinity Pharmaceuticals	United States Patent and Trademark Office	11110096	September 7, 2021
‌ US Patent 7851637 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners	Patent 7851637 was granted and assigned to Infinity Pharmaceuticals on December, 2010 by the United States Patent and Trademark Office.		Infinity Pharmaceuticals	United States Patent and Trademark Office	7851637	December 14, 2010
‌ US Patent 11541059 Heterocyclic compounds and uses thereof		Infinity Pharmaceuticals	Infinity Pharmaceuticals	United States Patent and Trademark Office	11541059	January 3, 2023
‌ US Patent 9115141 Substituted isoquinolinones and methods of treatment thereof	Patent 9115141 was granted and assigned to Infinity Pharmaceuticals on August, 2015 by the United States Patent and Trademark Office.	Infinity Pharmaceuticals	Infinity Pharmaceuticals	United States Patent and Trademark Office	9115141	August 25, 2015
‌ US Patent 9255108 Heterocyclic compounds and uses thereof	Patent 9255108 was granted and assigned to Infinity Pharmaceuticals on February, 2016 by the United States Patent and Trademark Office.	Infinity Pharmaceuticals	Infinity Pharmaceuticals	United States Patent and Trademark Office	9255108	February 9, 2016
‌ US Patent 9527847 Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors	Patent 9527847 was granted and assigned to Infinity Pharmaceuticals on December, 2016 by the United States Patent and Trademark Office.	Infinity Pharmaceuticals	Infinity Pharmaceuticals	United States Patent and Trademark Office	9527847	December 27, 2016
‌ US Patent 9775844 Heterocyclic compounds and uses thereof	Patent 9775844 was granted and assigned to Infinity Pharmaceuticals on October, 2017 by the United States Patent and Trademark Office.	Infinity Pharmaceuticals	Infinity Pharmaceuticals	United States Patent and Trademark Office	9775844	October 3, 2017
‌ US Patent 10406139 Cyclopamine analogs	Patent 10406139 was granted and assigned to Infinity Pharmaceuticals on September, 2019 by the United States Patent and Trademark Office.	Infinity Pharmaceuticals	Infinity Pharmaceuticals	United States Patent and Trademark Office	10406139	September 10, 2019
‌ US Patent 11007181 Cyclopamine analogs	Patent 11007181 was granted and assigned to Infinity Pharmaceuticals on May, 2021 by the United States Patent and Trademark Office.	Infinity Pharmaceuticals	Infinity Pharmaceuticals	United States Patent and Trademark Office	11007181	May 18, 2021
‌ US Patent 8927551 Isoxazolines as inhibitors of fatty acid amide hydrolase	Patent 8927551 was granted and assigned to Infinity Pharmaceuticals on January, 2015 by the United States Patent and Trademark Office.		Infinity Pharmaceuticals	United States Patent and Trademark Office	8927551	January 6, 2015
‌ US Patent 8227509 Methods of use of cyclopamine analogs	Patent 8227509 was granted and assigned to Infinity Pharmaceuticals on July, 2012 by the United States Patent and Trademark Office.		Infinity Pharmaceuticals	United States Patent and Trademark Office	8227509	July 24, 2012
‌ US Patent 9605003 Heterocyclic compounds and uses thereof	Patent 9605003 was granted and assigned to Infinity Pharmaceuticals on March, 2017 by the United States Patent and Trademark Office.	Infinity Pharmaceuticals	Infinity Pharmaceuticals	United States Patent and Trademark Office	9605003	March 28, 2017

...

Results per page:

105 results

0 selected

105 results

0 selected